Top

Published in:

01-06-2012 | Original Article

Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma

Authors: B. Amend, J. Hennenlotter, M. Scharpf, S. Kruck, U. Kuehs, E. Senger, A. S. Merseburger, M. A. Kuczyk, K. D. Sievert, A. Stenzl, J. Bedke

Published in: World Journal of Urology | Issue 3/2012

Abstract

Purpose

Renal oncocytomas are assigned as benign tumours, and their detailed molecular mechanism is poorly characterised. Activation of the PKB/Akt pathway is assumed to contribute to the pathogenesis and progression of malignant disease. For oncocytomas, hardly any data are available for Akt signalling parameters. Aim of the present work was to determine the alterations of Akt parameters PTEN, phosphorylated Akt (p-Akt) and p27^Kip1 in oncocytoma to better understand the dedifferentiation of renal tumours.

Methods

By tissue microarray analysis 15 oncocytoma, 18 clear cell renal cell carcinoma (ccRCC) and the corresponding benign tissue were investigated. Significant expression differences between PTEN, p-Akt and p27^Kip1 were determined by immunohistochemistry using One-way ANOVA with all pairs Tukey–Kramer as post hoc analyses. To investigate Akt parameter interactions in the oncocytoma, linear regression analyses were performed.

Results

Expression of all proteins was significantly different between the groups and in all groups the lowest for oncocytoma: PTEN: 32.9 ± 13.0 versus 75.5 ± 8.0 versus 123.7 ± 8.8; p < 0.001 for oncocytoma, benign parenchyma and ccRCC and 2.7 ± 1.2 versus 40.8 ± 9.5 versus 143.6 ± 12.2; p < 0.001 for p27^Kip1. p-Akt expression was significantly different between oncocytoma and ccRCC (67.3 ± 15.7 vs. 144.0 ± 26.6; p < 0.05).

Conclusion

All three investigated parameters were the lowest in oncocytoma when compared to ccRCC. Expression of PTEN and p27^Kip1 seems to be exceedingly associated with malignant conditions of ccRCC. These findings might contribute to the understanding of tumorous signalling of the PKB/Akt axis in renal tumours.

Romis L et al (2004) Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database. Eur Urol 45:53–57 (discussion 57)PubMedCrossRef

Eble JN (2004) Tumors at the kidney, chap 1. In: Eble JN, Sauter G, Epstein JI (eds) Pathology and genetics of tumours of the urinary system and male genital organs. World Health Organisation classification of tumours. IARC Press, Lyons, pp 9–88

Van der Kwast T, Perez-Ordonez B (2007) Renal oncocytoma, yet another tumour that does not fit in the dualistic benign/malignant paradigm? J Clin Pathol 60:585–586PubMedCrossRef

Gudbjartsson T et al (2005) Renal oncocytoma: a clinicopathological analysis of 45 consecutive cases. BJU Int 96:1275–1279PubMedCrossRef

Cheng L et al (2009) Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol 40:10–29PubMedCrossRef

Cossu-Rocca P et al (2008) Interphase cytogenetic analysis with centromeric probes for chromosomes 1, 2, 6, 10, and 17 in 11 tumors from a patient with bilateral renal oncocytosis. Mod Pathol 21:498–504PubMedCrossRef

Fuzesi L et al (1994) Renal oncocytoma with a translocation t(9;11) (p23;q13). J Urol 152:471–472PubMed

Rohan S et al (2006) Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes. Clin Cancer Res 12:6937–6945PubMedCrossRef

Escudier B et al (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356:125–134PubMedCrossRef

10.

Motzer RJ et al (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356:115–124PubMedCrossRef

11.

Song G, Ouyang G, Bao S (2005) The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9:59–71PubMedCrossRef

12.

Altomare DA, Testa JR (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24:7455–7464PubMedCrossRef

13.

Samuels Y, Ericson K (2006) Oncogenic PI3 K and its role in cancer. Curr Opin Oncol 18:77–82PubMedCrossRef

14.

Brenner W et al (2002) Loss of tumor suppressor protein PTEN during renal carcinogenesis. Int J Cancer 99:53–57PubMedCrossRef

15.

Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663PubMedCrossRef

16.

Merseburger AS et al (2006) Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesions. Oncol Rep 16:79–83PubMed

17.

Merseburger AS et al (2005) Cathepsin D expression in renal cell cancer-clinical implications. Eur Urol 48:519–526PubMedCrossRef

18.

Pantuck AJ et al (2007) Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy. Cancer 109:2257–2267PubMedCrossRef

19.

Downes CP et al (2001) Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN. Biochem Soc Trans 29:846–851PubMedCrossRef

20.

Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240–4245PubMedCrossRef

21.

Vazquez F, Sellers WR (2000) The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim Biophys Acta 1470:M21–M35PubMed

22.

Slingerland J, Pagano M (2000) Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183:10–17PubMedCrossRef

23.

Hennenlotter J et al (2008) PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas-implications for Akt activation. Oncol Rep 19:1141–1147PubMed

24.

Breen EC (2007) VEGF in biological control. J Cell Biochem 102:1358–1367PubMedCrossRef

25.

Guijarro MV et al (2007) MAP17 inhibits Myc-induced apoptosis through PI3 K/AKT pathway activation. Carcinogenesis 28:2443–2450PubMedCrossRef

26.

Ignatoski KMW et al (2003) The role of phosphatidylinositol 3′-kinase and its downstream signals in erbB-2-mediated transformation. Mol Cancer Res 1:551–560

27.

Kruck S et al (2011) High cytoplasmic expression of p27Kip1 is associated with a worse cancer-specific survival in clear cell renal cell carcinoma. BJU Int (in press)

28.

Viglietto G, Motti ML, Fusco A (2002) Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization. Cell Cycle 1:394–400PubMedCrossRef

Title: Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma
Authors: B. Amend
J. Hennenlotter
M. Scharpf
S. Kruck
U. Kuehs
E. Senger
A. S. Merseburger
M. A. Kuczyk
K. D. Sievert
A. Stenzl
J. Bedke
Publication date: 01-06-2012
Publisher: Springer-Verlag
Published in: World Journal of Urology / Issue 3/2012
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-011-0737-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2012

Androgen receptor footprint on the way to prostate cancer progression

Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy

The clinical impact of pathological review on selection the treatment modality for localized prostate cancer in candidates for brachytherapy monotherapy

Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells

Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia

When is it necessary to perform nuclear renogram in patients with a unilateral neonatal hydronephrosis?